Prescription drug · ANDA
Allopurinol NDC 85766-288
Allopurinol 300 mg/1 · Tablet · Oral · Sportpharm LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85766-288-01 | 85766028801 | 100 TABLET in 1 BOTTLE (85766-288-01)Marketed from Sep 29, 2026 | |
| 85766-288-10 | 85766028810 | 10 TABLET in 1 BOTTLE (85766-288-10)Marketed from Sep 29, 2026 | |
| 85766-288-15 | 85766028815 | 15 TABLET in 1 BOTTLE (85766-288-15)Marketed from Sep 29, 2026 | |
| 85766-288-20 | 85766028820 | 20 TABLET in 1 BOTTLE (85766-288-20)Marketed from Sep 29, 2026 | |
| 85766-288-30 | 85766028830 | 30 TABLET in 1 BOTTLE (85766-288-30)Marketed from Sep 29, 2026 | |
| 85766-288-60 | 85766028860 | 60 TABLET in 1 BOTTLE (85766-288-60)Marketed from Sep 29, 2026 | |
| 85766-288-90 | 85766028890 | 90 TABLET in 1 BOTTLE (85766-288-90)Marketed from Sep 29, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Allopurinol
- Generic name (nonproprietary)
- allopurinol
- Active ingredients
- Allopurinol — 300 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Sportpharm LLCNDC labeler code 85766
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215091
- Marketing start
- Listing expires
- Other FDA classes
- Xanthine Oxidase Inhibitors (Mechanism)
- Identifiers
- Product ID 85766-288_5c99f702-23e1-6fb6-e063-6294a90aeea1SPL ID 5c99f702-23e1-6fb6-e063-6294a90aeea1
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485766028801followed by a unit qualifier and the quantityPackage 85766-0288-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 85766-288
- What is NDC 85766-288?
- 85766-288 is the product NDC for Allopurinol, Allopurinol 300 mg/1 tablet, listed with the FDA by Sportpharm LLC. It has 7 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Allopurinol.
- What is the active ingredient?
- Allopurinol.
- Who is the labeler?
- Sportpharm LLC, NDC labeler code 85766. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Allopurinol?
- 167 other product NDCs are listed under this name. See all Allopurinol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Allopurinol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-0282 | 55154-0282-00 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4693 | 70518-4693-00 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Safecor Health, LLC | 48433-002 | 48433-0002-20 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Safecor Health, LLC | 48433-003 | 48433-0003-20 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Coupler LLC | 67046-1658 | 67046-1658-03 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4556 | 70518-4556-00 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-099 | 82868-0099-3082868-0099-90 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 53401-019 | 53401-0019-6053401-0019-80 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 53401-025 | 53401-0025-60 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | XLCare Pharmaceuticals Inc. | 72865-303 | 72865-0303-0172865-0303-0572865-0303-10+1 more |
Other NDCs under ANDA 215091
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-285 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-286 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-593 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-596 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Sportpharm LLC | 85766-287 |